Literature DB >> 15498783

Oncogene regulation of tumor suppressor genes in tumorigenesis.

Jimmy Sung1, Joel Turner, Susan McCarthy, Steve Enkemann, Chan Gong Li, Perally Yan, Timothy Huang, Timothy J Yeatman.   

Abstract

We attempted to demonstrate whether there is an epigenetic link between oncogenes and tumor suppression genes in tumorigenesis. We designed a high throughput model to identify a candidate group of tumor suppressor genes potentially regulated by oncogenes. Gene expression profiling of mock-transfected versus v-src-transfected 3Y1 rat fibroblasts identified significant overexpression of DNA methyltransferase 1, the enzyme responsible for aberrant genome methylation, in v-src-transfected fibroblasts. Secondary microarray analyses identified a number of candidate tumor suppressor genes that were down-regulated by v-src but were also re-expressed following treatment with 5-aza-2'-deoxycytidine, a potent demethylating agent. This candidate group included both tumor suppressor genes that are known to be silenced by DNA hypermethylation and those that have not been previously identified with promoter hypermethylation. To further validate our model, we identified tsg, a tumor suppressor gene that was shown to be down-regulated by v-src and found to harbor dense promoter hypermethylation. Our model demonstrates a cooperative relationship between oncogenes and tumor suppressor genes mediated through promoter hypermethylation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15498783     DOI: 10.1093/carcin/bgh318

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  6 in total

Review 1.  Pro-oncogenic and anti-oncogenic pathways: opportunities and challenges of cancer therapy.

Authors:  Jiao Zhang; Yan-Hua Chen; Qun Lu
Journal:  Future Oncol       Date:  2010-04       Impact factor: 3.404

2.  Down-regulation of the tumor suppressor C-terminal Src kinase (Csk)-binding protein (Cbp)/PAG1 is mediated by epigenetic histone modifications via the mitogen-activated protein kinase (MAPK)/phosphatidylinositol 3-kinase (PI3K) pathway.

Authors:  Kei Suzuki; Chitose Oneyama; Hironobu Kimura; Shoji Tajima; Masato Okada
Journal:  J Biol Chem       Date:  2011-03-09       Impact factor: 5.157

3.  Expression and functional analysis of the WAP four disulfide core domain 1 gene in human melanoma.

Authors:  Suhu Liu; Paul Howell; Suping Ren; Oystein Fodstad; Guangyu Zhang; Rajeev Samant; Lalita Shevde; Yaguang Xi; Lewis K Pannell; Adam I Riker
Journal:  Clin Exp Metastasis       Date:  2009-06-02       Impact factor: 5.150

4.  Inhibitory mechanism of FAT4 gene expression in response to actin dynamics during Src-induced carcinogenesis.

Authors:  Takao Ito; Hiroaki Taniguchi; Kousuke Fukagai; Shota Okamuro; Akira Kobayashi
Journal:  PLoS One       Date:  2015-02-13       Impact factor: 3.240

5.  Ras oncogene-mediated progressive silencing of extracellular superoxide dismutase in tumorigenesis.

Authors:  Francesca Cammarota; Gabriella de Vita; Marco Salvatore; Mikko O Laukkanen
Journal:  Biomed Res Int       Date:  2015-10-15       Impact factor: 3.411

6.  Tumor suppressor genes and allele-specific expression: mechanisms and significance.

Authors:  Evan A Clayton; Shareef Khalid; Dongjo Ban; Lu Wang; I King Jordan; John F McDonald
Journal:  Oncotarget       Date:  2020-01-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.